dr reddy semaglutide Reddy's Launches Injection In Canada; Estimated To Be A $120 Million Opportunity Dr Reddy's Semaglutide Woes Ripple

Hers generally follows FDA guidelines for GLP-1 eligibility: a BMI of 30 or higher, or 27+ with at least one weight-related condition (such as type 2 diabetes, high blood pressure, or sleep apnea)

As your glucose stores become depleted, low blood sugar may result

The key patient-side decision is matching the delivery method to the goal: topical for skin-only applications, injectable (through a clinic) for hair or systemic goals

Individual variation is real

Ledisa leaned into that science while staying focused on something even more practical: whether a woman who's already juggling a full life would actually use it

Online reviews often reflect outlier outcomes or include confounding lifestyle changes